SS Innovations International, Inc.

SSII ·Healthcare, Medical Devices
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-12.1M $-19.2M $-20.9M $-3.2M $-1.5M $-1.1M $-3.4M $-960.3K
Depreciation & Amortization $1.1M $436.0K $152.7K $96.6K $18.8K $37.4K $37.7K $19.5K
Depreciation $1.1M $436.0K $162.6K $128.9K — — — —
Amortization — — — — — — — —
Stock-Based Compensation $8.1M $14.3M $9.7M $865.5K $767.2K $434.2K $1.1M $76.0K
Net Cash from Operating Activities $-18.5M $-9.5M $-15.4M $-6.0M $-363.0K $-90.5K $-424.1K $-443.3K
Investing Activities
Capital Expenditures $3.7M $661.5K $453.3K $220.3K — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-3.7M $-661.5K $-453.3K $240.8K $38.2K $-44.0K $-50.1K $-23.6K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — $26.0K — — —
Net Cash from Financing Activities $26.2M $9.4M $22.8M $5.9M $569.9K $266.8K $467.0K $50.0K
Net Change in Cash — — — $-945.6K $245.1K — $-7.2K $-416.9K
Free Cash Flow $-22.2M $-10.2M $-15.8M $-6.2M — — — —
← Newer Page 1 of 2 Older →